What question did this study set out to answer?

The aim is to evaluate the potential of rutin as a senomorphic agent to target senescent cells and enhance chemotherapy effectiveness.

July 20, 2023Aging CellOpen Access

Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial shows rutin improves chemotherapeutic outcomes in aging-related conditions, suggesting its therapeutic potential.

The aim is to evaluate the potential of rutin as a senomorphic agent to target senescent cells and enhance chemotherapy effectiveness.
Screening of a natural medicinal agent library for senotherapeutics.
Validation of rutin's capacity to dampen SASP and ASAP pathways via ATM interactions.
Assessment of rutin's impact on malignant phenotypes of prostate cancer cells under chemotherapy.
Rutin significantly reduced SASP expression, HR not reported, p<0.05.
Combination of rutin with traditional chemotherapy improved tumor outcomes, exact metrics not specified.
Rutin diminished aggressive traits of prostate cancer cells influenced by senescent cell media, qualitative improvement noted.

Liu et al. (2023) studied this question.

View Full Paper

Ask AI

Bookmark